Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 3Lung Neoplasms 2Carcinoma, Hepatocellular 2Upper Tract Urothelial Carcinoma 1Unresectable Hepatocellular Carcinoma 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Sarcoma 1Radiation Injuries 1Pathologic Complete Response 1Pancreatic Cancer Liver Metastases 1Neoadjuvant Immunotherapy 1Muscle-invasive Bladder Cancer 1Locally Advanced Rectal Adenocarcinoma 1Locally Advanced Pancreatic Cancer 1Locally Advanced Cervical Carcinoma 1Hyperthermia 1HER2-Negative Locally Advanced Breast Cancer 1Gynecologic Cancers 1Gastrointestinal Neoplasms 1Gastric Cancer With Liver Metastases 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1Colorectal Neoplasms 1Carcinoma 1Breast Neoplasms 1Advanced Rectal Cancer 1

Interventions

Carboplatin 3Radiotherapy, Intensity-Modulated 2Radiotherapy 2selinexor 1ponatinib 1poly ICLC 1pemigatinib 1neratinib 1donafenib 1cobimetinib 1ceritinib 1cemiplimab 1brigatinib 1abemaciclib 1Thymopentin 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiation 1Pluvicto 1Platinum Compounds 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Neck Dissection 1NF protocol 1Magnetic Resonance Spectroscopy 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma × Immunotherapy × Clear all
NCT07135882 2025-08-22

PRIME-Lung

Trans Tasman Radiation Oncology Group

Phase 3 Not yet recruiting
420 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡